Thus, in a TNF-alpha enriched environment, RCC cells may counteract immune recognition by decreasing endothelial ICAM-1, VCAM-1 and E-selectin expression to inhibit leukocyte extravasation. This evidence concerns the gene VCAM1 and renal cell carcinoma.